Oncological outcome after MRI-based selection for neoadjuvant chemoradiotherapy in the OCUM Rectal Cancer Trial.
R RuppertTheodor JungingerH PtokJ StrassburgC A MaurerP BrosiJ SauerJ BaralM KreisD WollschlaegerP HermanekSusanne Merkelnull nullPublished in: The British journal of surgery (2018)
Restriction of nCRT to high-risk patients achieved good results.
Keyphrases
- rectal cancer
- locally advanced
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- clinical trial
- magnetic resonance imaging
- prognostic factors
- squamous cell carcinoma
- lymph node
- prostate cancer
- magnetic resonance
- phase ii
- phase iii
- diffusion weighted imaging
- minimally invasive
- double blind
- open label
- radical prostatectomy
- placebo controlled